Pipeline Insight, 2025 ” explores a dynamic portfolio of emerging therapies poised to redefine management. Next-generation ...

Zacks spotlights Roche, Linde, Disney, and Vaso as analysts weigh drug demand, gas contracts, global expansion, and IT-driven resilience.

Oral presentation to include topline efficacy and safety data for 6 patients with up to 9 months of follow up? Enrollment for registrational Phase 3 portion of KYSA-6 trial in MG on track to initiate ...

Micah Parsons said he's been dealing with with a sprained L4-L5 facet joint in his spine. The cure seems to have been a change of scenery and a new contract, ...

Oral presentation to include topline efficacy and safety data for 6 patients with up to 9 months of follow up​Enrollment for registrational Phase ...

In Australia and EuropeMADRID and CAMBRIDGE, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European ...